Jump to the main content block

Mei-Chiun Tseng

 
Extension E-mail/Homepage
4629 mctseng@mail.nsysu.edu.tw

Biography

Mei-Chiun Tseng is a professor at the Department of Business Management, National Sun Yat-Sen University. Her primary expertise is managerial economics, which is also her main teaching responsibility at the faculty. Since 2001, her research has focused on public health issues related to stroke. Mei-Chiun's current research projects include modelling stroke trends in Taiwan, prevention strategy in reducing the burden of stroke, and cost-effectiveness of healthcare interventions. 

She received her BA in International Trade at the National Taiwan University and PhD in Managerial Economics and Decision Sciences at Northwestern University.

AREA of EXPERTISE

Managerial Economics, Health Services Research

WORK HISTORY

2003-present

Professor, Department of Business Management, National Sun Yat-Sen University

1990-2003

Associate Professor, Department of Business Management, National Sun Yat-Sen University

1988-1990

Visiting Associate Professor, Department of Business Management, National Sun Yat-Sen University

1986-1988

Lecturer and Teaching Assistant, Department of Managerial Economics and Decision Sciences, J. L. Kellogg Graduate School of Management, Northwestern University

1982-1983

Teaching Assistant, Department of Business Management, National Sun Yat-Sen University

EDUCATION

1988        Ph.D. (Managerial Economics and Decision Sciences), Northwestern University, USA
1982        B.B.A. National Taiwan University

PUBLICATIONS

Refereed Academic Journals(Since 2004)

 

  • Lin HJ, Chang WL, Tseng MC. Readmission after Stroke in a Hospital-Based Registry: Risk, Etiologies, and Risk Factors. Neurology, 2011;76:438-443.

  • Lee TH, Tseng MC, Chen CJ, Lin JL. Association of High Body Lead Store with Severe Intracranial Carotid Atherosclerosis. Neurotoxicology, 2009 ;30:876-880 .

  • Tseng MC, Lin HJ. Readmission after Hospitalization for Stroke in Taiwan: Results from a National Sample. J Neurol Sci, 2009; 284:52-55.

  • Den Hertog HM, van der Worp HB, Tseng MC, Dippel DWJ. Temperature-Lowering Therapy for Acute Stroke, Stroke, 2009;40:e481-e482 (Cochrane Corner).

  • Den Hertog HM, van der Worp HB, Tseng MC, Dippel DWJ. Cooling Therapy for Acute Stroke. Cochrane Database Syst Rev, 2009, Issue 1.

  • Whiteley WN, Tseng MC, Sandercock P. Blood Biomarkers in the Diagnosis of Ischaemic Stroke: a Systematic Review, Stroke, 2008;39:2902-2909.

  • Tseng MC, Sandercock P, Counsell C. Anticoagulants for Acute Ischemic Stroke,Chest, 2008;134;466 (Letter to the Editor).

  • Sandercock P, Counsell C, Tseng MC. Low-Molecular-Weight Heparins or Heparinoids versus Standard Unfractionated Heparin for Acute Ischaemic Stroke,Cochrane Database Syst Rev, 2008, Issue 3.

  • Sandercock P, Counsell C, Gubitz GJ, Tseng MC. Antiplatelet Therapy for Acute Ischaemic Stroke, Cochrane Database Syst Rev, 2008, Issue 3.

  • Tseng MC, Lin HJ. Health-Related Quality of Life after Stroke: Review of the Literature and Implications for Future Research, Acta Neurol Taiwan, 2007;16:7-12.

  • Tseng MC, Lin HJ, Chang KC. The State of Outcomes Research in Stroke: What We Conclude from the Annual Meetings of the Taiwan Stroke Society, Int J Stroke, 2006;1:235-237.

  • Tseng MC, Chang KC. Stroke Severity and Early Recovery after First-Ever Ischemic Stroke: Results of a Hospital-Based Study in Taiwan, Health Policy, 2006;79:73-78.

  • Chang KC, Tseng MC, Tan TY, Liou CW. Predicting 3-Month Mortality among Patients Hospitalized for First-Ever Acute Ischemic Stroke, J Formos Med Assoc, 2006;105:310-317.

  • Tseng MC, Chang KC, Lin HJ, Myth in TIA, Taiwan Medical Journal, 2006;49:37-39. (In Chinese)

  • Tseng MC, Chang KC, Measurement and Classification of Stroke Severity, Taiwan Medical Journal, 2005;48:101-104. (In Chinese)

  • Tan TY, Tseng MC, Chang KC. Risk Factors for First-Ever Ischemic Stroke: A Hospital-Based Case-Control Study in Kaohsiung, Taiwan, Chang Gung Med J, 2004;27:801-807.

  • Tseng MC, Chang KC. Cost-Effectiveness Analysis of Tissue Plasminogen Activator for Acute Ischemic Stroke: A Comparative Review, Acta Neurol Taiwan, 2004;13:149-155.

  • Tseng MC, Chang KC, Cerebrovascular Disease, Epidemiology and Resource Utilization in Taiwan, Taiwan Medical Journal, 2004;47:281-283. (In Chinese).

  • Chang KC, Tseng MC, Tan TY. Prehospital Delay after Acute Stroke in Kaohsiung, Taiwan, Stroke, 2004;35:700-704.

Conference Papers(since 2004)

  • Lin HJ, Tseng MC, Chen YW. Derivation and Validation of a Clinical System for Predicting Readmission after First-Ever Stroke, presented at 20th European Stroke Conference. Hamburg, Germany, May 24-27, 2011.

  • Lin HJ, Yeh PS, Chen YW, Sung SF, Tseng MC. Causes of Readmission after First-Ever Stroke in Taiwan by Functional Dependence at Discharge, presented at 20th European Stroke Conference. Hamburg, Germany, May 24-27, 2011.

  • Sung SF, Chen YW, Tseng MC, Lin HJ. Comparison of outcomes following Intravenous rt-PA treatment amongst patients with or without atrial fibrillation, presented at 20th European Stroke Conference. Hamburg, Germany, May 24-27, 2011.

  • Tseng MC, Liu JS, Lin HJ. Readmission after Hospitalization for First-Ever Stroke in Taiwan: 1998 to 2003, presented at the 18th European Stroke Conference, Stockholm, Sweden, May 26-29, 2009.

  • Tseng MC, Liu JS, Lee CH, Hung HC. Hypertension and Risk of Stroke in Patients with Diabetes in Taiwan: a Nationwide Observation, presented in the 2nd International Conference on Hypertension, Lipids, Diabetes & Stroke Prevention, Prague, Czech Republic, March 6-8, 2008.

  • Tseng MC, Chang KC, Liu JS. Thrombolytic Therapy in Acute Ischemic Stroke in Taiwan, presented at Glasgow, UK, 2007.

  • Tseng MC. Readmission of Hospitalized Stroke Patients in Taiwan: Results from a National Sample, presented at Joint World Congress on Stroke: International Stroke Society, Mediterranean Stroke Society and Southern African Stroke Foundation, Cape Town, South Africa, 2006.

  • Tseng MC, Chang KC, Lin HJ, Lin TK, Tan TY. Predicting Costs of Acute Hospitalization for First-Ever Ischemic Stroke in Taiwan, presented at the AcademyHealth 2006 Annual Research Meeting, Seattle, Washington, USA, 2006.

  • Tseng MC, Chang KC. Resources use and outcomes of acute care for first-ever ischemic stroke in Taiwan: short vs. prolonged stay patients, presented at the ISPOR 2nd Asia-Pacific Conference, Shanghai, China, 2006.

  • Tseng MC, Chang KC. Factors related to longer acute stay after first-ever ischemic stroke, presented at the ISPOR 8th Annual European Congress, Florence, Italy, 2005.

  • Chang KC, Tseng MC, Hung JW, Lin TK, Tan TY, Chen CH. Mandarin Version of Stroke impact scale: Adaptation and Validation, presented at the ISPOR 8th Annual European Congress, Florence, Italy, 2005.

  • Tseng MC, Chang KC. Acute Care of First-Ever Ischemic Stoke in Taiwan: Outcomes and Implications for Healthcare Resource Utilization, presented at the 2005 iHEA World Congress in Barcelona, Spain, 2005.

  • Tseng MC, Chang KC. Stroke Severity and Early Outcomes after First-Ever Ischemic Stroke, presented at the ISPOR 7th Annual European Congress, Hamburg, Germany, 2004.

  • Tseng MC, Chang KC. Cost-Effectiveness of Thrombolysis with rt-PA for Acute Ischemic Stroke in Taiwan, presented at the ISPOR 7th Annual European Congress, Hamburg, Germany, 2004.

  • Chang KC, Tseng MC. “Three-Year Survival after First-Ever Ischemic Stroke in Taiwan: A Hospital-Based Study,” presented at the 13th European Stroke Conference, Mannheim-Heidelberg, Germany, 2004.

Other Publications

PROJECTS (since 2004)

 

  • Derivation and Validation of a Clinical System for Predicting Readmission after Stroke (NSC100-2410-H-110-051)

  • Readmission after Hospitalization for Stroke in Taiwan (NSC 97-2410-H-110-010-MY2)

  • Modeling the Future Burden of Stroke in Taiwan (NSC 95-2416-H-110-009-MY2)

  • A comparison of use of QALYs and DALYs in cost-effectiveness analysis -- the case of treatment of acute stroke (NSC 94-2416-H-110 -024)

  • A Study on Treatment Outcome of Acute Hospitalization for First-Ever Ischemic Stroke (NSC 93-2416-H-110-031)

TEACHING EXPERIENCE 2004-2009

Degree

Course

Doctoral

N/A

MBA

Evidence-Based Medicine Research Method (1001).
Managerial Economics (1001).
Evidence-Based Medicine Research Method (982).
Managerial Economics (981).
Evidence-Based Medicine Research Method (972).
Managerial Economics (971).
Comparative Study on Cross-Strait Business Management (961).

Part-time MBA

N/A

BBA

Economics (972).
Economics Practice (972).
Microeconomics (962).
Economics (961).
Economics Practice (961).
Economics (Section A) (951).
Economics Practice (Section A) (951).
Economics (Section B) (951).
Economics Practice (Section B) (951).
Economics (942).
Economics Practice (942).
Economics (MIS) (942).
Economics (941).
Economics Practice (941).
Microeconomics (941).
Economics (section A) (932).
Economics Practice (section A) (932).
Economics (section B) (932).
Economics Practice (section B) (932).

SERVICES

Year

Title

AWARDS

Period

Title

Dec 2002-Feb 2003

Visiting exchange fellow (sponsored by the National Science Council, Taiwan), International Institute for Asian Studies (IIAS), The Netherlands.

1987-1988

Nancy L. Schwartz Award, J. L. Kellogg Graduate School of Management, Northwestern University.

1985-1986

Fellowship, J. L. Kellogg Graduate School of Management, Northwestern University.

1983-1985

Graduate Scholarship, J. L. Kellogg Graduate School of Management, Northwestern University.

PROFESSIONAL MEMBERSHIPS

Period

Title